Abstract
Since the South Korean government designated personalized medicine (PM) as a national strategic task in 2016, it has spared no investment to achieve its goals, which were recently accelerated by the COVID-19 pandemic. This study analyzed investment trends in 17 regions and eight technology clusters related to PM, consisting of 5727 public R&D projects worth USD 148.5 million, from 2015 to 2020. We also illustrated the level of investment for different PM-related technology clusters in each region; various research organizations explicitly verified comparable innovation capabilities for all eight technology fields in 17 regions, showing individual differences in technology areas per region. Our framework provided information to allow implementation of two goals: administering successful PM and improving regional equality in public health and healthcare according to technical and organizational levels. This study empirically demonstrates that it can provide a precise overarching innovation scheme with regional, technical, and organizational dimensions to establish collaboration among different stakeholders, thereby creating a foundation for an overarching national PM strategy.
Highlights
Academic Editor: PaulDue to the ongoing healthcare reforms worldwide, cost-containment strategies, and advancement in new technologies and diagnostic tests [1], leading governments have recognized the importance of personalized or precision medicine (PM) as a potent engine driving economic growth
The US Precision Medicine Initiative is a long-term research endeavor to develop a new model of individualized care with a USD 9269 million investment from 2016 to 2020 [7,8] while Personalised Medicine” (PerMed) and ICPerMed focused on coordinating and fostering research to develop and evaluate PM approaches at the European and international levels with
Korean precision medical cohort of 100,000 volunteers, aligning with international standards that can be linked with overseas precision medical cohort information and a medical information integration system for hospitals and drug developers to jointly use genome, medical, and health information owned by individual institutions; (2) develop a Clinical Decision Supporting System that assists personalized diagnosis and prescription by analyzing bigdata on PM using artificial intelligence (AI) technology; (3) initiate a PM
Summary
Academic Editor: PaulDue to the ongoing healthcare reforms worldwide, cost-containment strategies, and advancement in new technologies and diagnostic tests [1], leading governments have recognized the importance of personalized or precision medicine (PM) as a potent engine driving economic growth. The US Precision Medicine Initiative is a long-term research endeavor to develop a new model of individualized care with a USD 9269 million investment from 2016 to 2020 [7,8] while PerMed and ICPerMed focused on coordinating and fostering research to develop and evaluate PM approaches at the European and international levels with. After these announcements, other governments, including South Korea, Japan, and China, set out their national PM strategies. Korean precision medical cohort of 100,000 volunteers, aligning with international standards that can be linked with overseas precision medical cohort information and a medical information integration system for hospitals and drug developers to jointly use genome, medical, and health information owned by individual institutions; (2) develop a Clinical Decision Supporting System that assists personalized diagnosis and prescription by analyzing bigdata on PM using artificial intelligence (AI) technology; (3) initiate a PM (prevention, diagnosis, and treatment) trial service for three major cancers (lung, stomach, and colorectal) [11]. We should assess the landscape in terms of which government agencies of South
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International journal of environmental research and public health
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
